Expanding research and development of novel agents for the treatment and prevention of chemotherapy-induced alopecia

Bibliography

• SCHLESSINGER J, ULRICH A: Growth factor signaling by receptor tyrosine kinases. Neuron (1992) 9(3):383-391.
   Google Scholar
• RANDALL J, REAM E: Hair loss with chemotherapy: at a loss over its management? Eur. J. Cancer Care (Engl.) (2005) 14(3):223-231.
   Google Scholar
• CHRISTODOULOU C, KLOUVAS G, EFSTATHIOU E et al.: Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia. Oncology (2002) 62(2):97-102.
   PubMed Web of Science ®Google Scholar
• RIDDERHEIM M, BJURBERG M, GUSTAVSSON A: Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer (2003) 11(6):371-377.
   PubMed Web of Science ®Google Scholar
• DUVIC M, LEMAK NA, VALERO V et al.: A randomized trial of minoxidil in chemotherapy-induced alopecia. J. Am. Acad. Dermatol. (1996) 35(1):74-78.
   PubMed Web of Science ®Google Scholar
• SREDNI B, CASPI RR, KLEIN A et al.: A new immunomodulating compound (AS-101) with potential therapeutic application. Nature (1987) 330(6144):173-176.
   PubMed Web of Science ®Google Scholar
• SREDNI B, XU RH, ALBECK M et al.: The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models. Int. J. Cancer (1996) 65(1):97-103.
   PubMed Web of Science ®Google Scholar
• SREDNI B, GAL R, COHEN IJ et al.: Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression. FASEB J. (2004) 18(2):400-402.
   PubMedGoogle Scholar
• JAKOBISIAK M, BRUNO S, SKIERSKI J, DARAYNKIEWICZ Z: Cell cycle specific effects of lovastatin. Proc. Natl. Acad. Sci. (1991) 88:3628-3632.
   Google Scholar
• SCHILLI M, PAUS R, MENRAD A: Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol analogs. J. Invest. Dermatol. (1998) 111:598-604.
   Google Scholar
• JIMENEZ J: Protection from chemotherapy-induced alopecia by 1,25-dihydroxyvitamin D3. Cancer Res. (1992) 52:5123-5125.
   PubMed Web of Science ®Google Scholar
• KNOCKAERT M, GREENGARD P, MEIJER L: Pharmcological inhibitors of cyclin-dependent kinases. Trends Pharmacol. Sci. (2002) 23(9):417-425.
   Google Scholar
• DAVIS ST, BENSON BG, BRAMSON HN et al.: Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science (2001) 291(5501):134-137.
   PubMed Web of Science ®Google Scholar
• ARCK PC, HANDJISKI B, PETERS EM et al.: Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am. J. Pathol. (2003) 162(3):803-814.
   Google Scholar
• ARCK PC, HANDJISKI B, HAGEN E et al.: Indications for a 'brain-hair follicle axis (BHA)': inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J. (2001) 15(13):2536-2538.
   PubMedGoogle Scholar
• GERNER EW, MEYSKENS FL Jr: Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer (2004) 4(10):781-792.
   PubMed Web of Science ®Google Scholar
• HUANG Y, PLEDGIE A, CASERO RA Jr, DAVIDSON NE: Molecular mechanisms of polyamine analogs in cancer cells. Anticancer Drugs (2005) 16(3):229-241.
   PubMed Web of Science ®Google Scholar
• WASSERMAN TH, BRIZEL DM: The role of amifostine as a radioprotector. Oncology (Williston Park) (2001) 15(10):1349-1354 (Discussion 1357-1360).
   Google Scholar
• HO D, FAHL WE: Modification of glutathione levels in C3H/10T1/2 cells and its relationship to benzo(a)pyrene anti-7,8-dihydrodiol 9,10-epoxide-induced cytotoxicity. J. Biol. Chem. (1984) 259(18):11231-11235.
   PubMedGoogle Scholar
• PATLAKAS G, BOUROS D, TSANTEKIDOU-POZOVA S, KOUKOURAKIS MI: Triplet chemotherapy with docetaxel, gemcitabine and liposomal doxorubicin, supported with subcutaneous amifostine and hemopoietic growth factors, in advanced non-small cell lung cancer. Anticancer Res. (2005) 25(2B):1427-1431.
   PubMedGoogle Scholar
• GENG L, HANSON WR, MALKINSON FD: Topical or systemic 16, 16 dm prostaglandin E2 or WR-2721 (WR-1065) protects mice from alopecia after fractionated irradiation. Int. J. Radiat. Biol. (1992) 61(4):533-537.
   Google Scholar
• TSURUKI T, TAKAHATA K, YOSHIKAWA M: Anti-alopecia mechanisms of soymetide-4, an immunostimulating peptide derived from soy β-conglycinin. Peptides (2005) 26(5):707-711.
   PubMedGoogle Scholar
• TSURUKI T, TAKAHATA K, YOSHIKAWA M: A soy-derived immunostimulating peptide inhibits etoposide-induced alopecia in neonatal rats. J. Invest. Dermatol. (2004) 122(3):848-850.
   Google Scholar
• MAURER M, HANDJISKI B, PAUS R: Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am. J. Pathol. (1997) 150(4):1433-1441.
   Google Scholar
• WYSOCKI GP, DALEY TD: Hypertrichosis in patients receiving cyclosporine therapy. Clin. Exp. Dermatol. (1987) 12(3):191-196.
   Google Scholar
• YAMAMOTO S, KATO R: Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants. J. Dermatol. Sci. (1994) 7(Suppl.):S47-54.
   Google Scholar
• TAYLOR M, ASHCROFT AT, MESSENGER AG: Cyclosporin A prolongs human hair growth in vitro. J. Invest. Dermatol. (1993) 100(3):237-239.
   Google Scholar
• GAFTER-GVILI A, SREDNI B, GAL R, GAFTER U, KALECHMAN Y: Cyclosporin A-induced hair growth in mice is associated with inhibition of calcineurin-dependent activation of NFAT in follicular keratinocytes. Am. J. Physiol. Cell Physiol. (2003) 284(6):C1593-C1603.
   Google Scholar
• SHIRAI A, TSUNODA H, TAMAOKI T, KAMIYA T: Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice. J. Dermatol. Sci. (2001) 27(1):7-13.
   Google Scholar
• OHYAMA M, VOGEL JC: Gene delivery to the hair follicle. J. Investig. Dermatol. Symp. Proc. (2003) 8(2):204-206.
   Google Scholar
• LI L, HOFFMAN RM: The feasibility of targeted selective gene therapy of the hair follicle. Nat. Med. (1995) 1(7):705-706.
   PubMed Web of Science ®Google Scholar
• SATO N, LEOPOLD P, CRYSTAL RG: Effect of adenovirus-mediated expression of Sonic hedgehog gene on hair regrowth in mice with chemotherapy-induced alopecia. J. Natl. Cancer Inst. (2001) 93(24):1858-1864.
   Google Scholar
• PALADINI R, SALEH J, QIAN C, XU G, RUBIN L: Modulation of hair growth with small molecule agonists of the hedgehog signaling pathway. J. Invest. Dermatol. (2005) 125(4):638-646.
   Google Scholar
• FLANAGAN SP: 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet. Res. (1966) 8(3):295-309.
   PubMed Web of Science ®Google Scholar
• PANTELOURIS EM: Absence of thymus in a mouse mutant. Nature (1968) 217(126):370-371.
   PubMed Web of Science ®Google Scholar
• SUNDBERG JP, CORDY WR, KING LE JR: Alopecia areata in aging C3H/HeJ mice. J. Invest. Dermatol. (1994) 102(6):847-856.
   Google Scholar
• SCHUDDEKOPF K, SCHORPP M, BOEHM T: The whn transcription factor encoded by the nude locus contains an evolutionarily conserved and functionally indispensable activation domain. Proc. Natl. Acad. Sci. USA (1996) 93(18):9661-9664.
   Google Scholar
• LEE D, PROWSE DM, BRISSETTE JL: Association between mouse nude gene expression and the initiation of epithelial terminal differentiation. Dev. Biol. (1999) 208(2):362-374.
   PubMedGoogle Scholar
• MCGARVEY EL, BAUM LD, PINKERTON RC, ROGERS LM: Psychological sequelae and alopecia among women with cancer. Cancer Pract. (2001) 9(6):283-289.
   Google Scholar